Category Archives: Poor Research

Recent in: Poor Research

CanLyme director responds to Canadian Medical Association Journal article

Response to Doctors Gregson and Quach Robert G. Murray, DDS, Director, CanLyme Re: “The Lyme law” Zubek, 187:520-521doi:10.1503/cmaj.115-0029 The problem with Lyme disease in Canada will only continue to grow to the point where the numbers affected will simply overwhelm the idea that Lyme Borreliosis (LB) is hard to catch and easy to treat with a short round of antibiotics. Continues →

Doctor comments on Lyme disease treatment

[CanLyme note: It is very common for mainstream physicians who subscribe to the Infectious Disease Society of America guidelines to design studies in such a fashion that the outcome is pre-determined.  These studies have no value, nor scientific merit.  The divide is created intentionally.] Infectious Disease doctor, Sam Donta, responds to article, To the Editor: I am responding to the Continues →

A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library

Frontiers in Microbiology, May 23, 2016 Although currently recommended antibiotics for Lyme disease such as doxycycline or amoxicillin cure the majority of the patients, about 10–20% of patients treated for Lyme disease may experience lingering symptoms including fatigue, pain, or joint and muscle aches. Under experimental stress conditions such as starvation or antibiotic exposure, Borrelia burgdorferi can develop round body Continues →

Watch CTV news interview of Dr. Todd Hatchette. A very good example of how opinion, not science, is driving Lyme borreliosis policy in Canada… in spite of evidence presented by experts in Ottawa, May 15th to 17th, 2016.

[Lyme disease is actually Lyme borreliosis. an infection caused by many different strains/genotypes of Borrelia bacteria] How can one rationalize making progress from the patient’s expert perspective when officially, by tax payer funded microbiologists, opinion is put forward as fact with no supporting science. Dr. Todd Hatchette attended the recent three day conference in Ottawa during which a wide diversity Continues →

New Lyme Disease Study Reveals Strong Reporting Bias

David Michael Conner Huffington Post On March 31, the New England Journal of Medicine published a study that concludes, “In patients with persistent symptoms attributed to Lyme disease, longer-term antibiotic treatment did not have additional beneficial effects on health-related quality of life beyond those with shorter-term treatment.” Read full article

Physicians and patients weigh in on latest poorly designed study that raises the question, “Why?”, and, “Who is driving this spin?”

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease Comment “Persister research needs to account for morphological variability of Lyme The patient population studied was already a group that had shown persistence of disease. These would be “treatment failures” and more difficult cases. Even in this difficult population every group who received 2 weeks of IV ceftriaxone made Continues →

Chronic Lyme European PLEASE Trial—You know it’s spin when treatment “success” is called “failure”?

March 30th, 2016 Today a widely anticipated clinical trial on chronic Lyme disease from Europe called PLEASE was published in the New England Journal of Medicine (NEJM).  The press has given the trial a twenty trumpet salute with a MedPage headline reading “Long-Term Antibiotics Fail Again in Lyme Disease–Focus on Lyme and antibiotics for persistent symptoms called unhelpful.”  Here’s the Continues →

Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis.

[ CanLyme note: “Although rare”, yet they state in the same breath that “sudden cardiac death caused by Lyme disease might be an under-recognized entity”.  In other words, they have no idea because in the past decades they have not been looking and nor was Lyme disease considered in similar sudden cardiac deaths. The standard Borrelia burgdorferi serology is a Continues →

Return on Investment Slipping in Biomedical Research

[CanLyme note: Medical research should be of the highest standard of all research, but in many cases the opposite is true. A good example is the Infectious Disease Society of America and their published material. Much of it is no more than opinion, not reproducible, and certainly not worthy of publication yet they get broad coverage in medical journals that had Continues →

Montreal Gazette newspaper trashes Lyme Disease victims and then refuses to allow evidence based rebuttal – they prefer scientific “opinion” over scientific fact..

Recently, the Montreal Gazette newspaper published this article …  According to the Montreal Gazette we are scaring people by telling them we have a serious and growing problem, a problem echoed by the Public Health Agency of Canada. http://montrealgazette.com/health/opinion-lyme-disease-is-very-real-but-its-no-epidemic We asked for equal print space to write a rebuttal.  We were refused because the editor says the weight of the Continues →

Antibiotic Prophylaxis for Lyme Disease: How the Way of Reporting a Clinical Trial Can Alter the Perception of Effectiveness

Urba`Gonza´ lez, MD, PhD; Department of Dermatology, Clinica Plato´ , Barcelona, Spain “Comment I recommend the complementary reading of other commentaries about the applicability of this study. Shapiro, in an accompanying editorial,1 pointed out the difficulty in clinical practice to know the species, stage, degree of engorgement of the tick, and even the difficulty to determine if the “tick” is Continues →

Lyme Misdiagnosis Can Divert Patients From Correct Treatment

[CanLyme Note: We agree totally that a thorough diagnostic work-up should preclude any diagnosis.  Not everything is Lyme borreliosis.  What is so dismaying, however, is the focus of the US CDC MD’s on the few cases such as those listed in this article, while they ignore the tens of thousands of legitimate chronic Lyme disease cases. We in Canada are already Continues →

Why is the CDC Trying to Block an Accurate Lyme Disease Test?

Posted on January 16, 2014 By Bob Goodwin, an investor and medical device entrepreneur who lives in Mercer Island, Washington A recent article in Medscape is titled New Lyme Culture Test Failed CDC Analysis. At first I took the article and paper at face value, and tried to dig into the errors of a chronic-Lyme disease researcher. The only errors Continues →